我国基于临床缓解率替代终点上市抗癌新药的现状及特征研究
朱婷, 钟锦佳, 吴昊, 黄亚芳
Current Status and Characteristics of Novel Cancer Drugs Approved in China with Clinical Response Rate as a Surrogate Endpoint
ZHU Ting, ZHONG Jinjia, WU Hao, HUANG Yafang
中国全科医学
.
2025, (20): 2523
-2529
.
DOI: 10.12114/j.issn.1007-9572.2024.0475
